Skip to Content
Merck
All Photos(1)

Documents

204M-1

Sigma-Aldrich

ALK Protein (ALK-1) Mouse Monoclonal Antibody

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
NACRES:
NA.41

biological source

mouse

Quality Level

100
500

conjugate

unconjugated

antibody form

culture supernatant

antibody product type

primary antibodies

clone

ALK-1, monoclonal

description

For In Vitro Diagnostic Use in Select Regions (See Chart)

form

buffered aqueous solution

species reactivity

human

packaging

vial of 0.1 mL concentrate (204M-14)
vial of 0.5 mL concentrate (204M-15)
bottle of 1.0 mL predilute (204M-17)
vial of 1.0 mL concentrate (204M-16)
bottle of 7.0 mL predilute (204M-18)

manufacturer/tradename

Cell Marque

technique(s)

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:25-1:100

isotype

IgG3κ

control

anaplastic large cell lymphoma

shipped in

wet ice

storage temp.

2-8°C

visualization

cytoplasmic, nuclear

General description

ALK-1 is a novel fusion protein which is detected in 60% of Anaplastic Large Cell Lymphomas and has proven to indicate improved prognosis in the ALK-1 (+) group.

Quality


IVD

IVD

IVD

RUO

Linkage

ALK Protein Positive Control Slides, Product No. 204S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

Physical form

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

Preparation Note

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

Other Notes

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

Legal Information

Cell Marque is a trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

S Nakamura et al.
The American journal of surgical pathology, 21(12), 1420-1432 (1997-12-31)
The p80(NPM/ALK) expression activated by the t(2;5) (p23;q35) translocation recently has been shown to play an important role in the pathogenesis of anaplastic large cell lymphoma (ALCL). However, the clinicopathologic significance of identification of p80 among ALCL cases has not
B Falini et al.
The American journal of pathology, 153(3), 875-886 (1998-09-15)
The t(2;5)(p23;q35) translocation associated with CD30-positive anaplastic large cell lymphoma results in the production of a NPM-ALK chimeric protein, consisting of the N-terminal portion of the NPM protein joined to the entire cytoplasmic domain of the neural receptor tyrosine kinase
K A Cataldo et al.
The American journal of surgical pathology, 23(11), 1386-1392 (1999-11-11)
Anaplastic large cell lymphoma (ALCL) is associated with the t(2;5)(p23;q35) translocation involving the anaplastic lymphoma kinase gene (ALK) and the nucleophosmin gene (NPM), which result in expression of a novel fusion protein, NPM-ALK (p80). Clinicopathologic studies have shown that ALK

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service